<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="homocystinuria" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">homocystinuria</book-part-id>
      <title-group>
        <title>Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonym: Classic Homocystinuria</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sacharow</surname>
            <given-names>Stephanie J</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="homocystinuria.Tc.aff1"/>
          <email>stephanie.sacharow@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Picker</surname>
            <given-names>Jonathan D</given-names>
          </name>
          <degrees>MBChB, PhD</degrees>
          <xref ref-type="aff" rid="homocystinuria.Tc.aff2"/>
          <email>jonathan.picker@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Levy</surname>
            <given-names>Harvey L</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="homocystinuria.Tc.aff1"/>
          <email>harvey.levy@childrens.harvard.edu</email>
        </contrib>
      </contrib-group>
      <aff id="homocystinuria.Tc.aff1">Division of Genetics and Genomics<break/>Boston Children's Hospital<break/>Boston, Massachusetts</aff>
      <aff id="homocystinuria.Tc.aff2">Division Genetics and Genomics and Division of Psychiatry<break/>Boston Children's Hospital<break/>Boston, Massachusetts</aff>
      <pub-history>
        <date date-type="created">
          <day>15</day>
          <month>1</month>
          <year>2004</year>
        </date>
        <date date-type="updated">
          <day>18</day>
          <month>5</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>15</day>
          <month>8</month>
          <year>2005</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hos" document-type="chapter">Holt-Oram Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="huntington" document-type="chapter">Huntington Disease</related-object>
      <abstract id="homocystinuria.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Homocystinuria caused by cystathionine &#x003b2;-synthase (CBS) deficiency is characterized by involvement of the eye (ectopia lentis and/or severe myopia), skeletal system (excessive height, long limbs, scolioisis, and pectus excavatum), vascular system (thromboembolism), and CNS (developmental delay/intellectual disability). All four &#x02012; or only one &#x02012; of the systems can be involved; expressivity is variable for all of the clinical signs. It is not unusual for a previously asymptomatic individual to present in adult years with only a thromboembolic event that is often cerebrovascular. Two phenotypic variants are recognized, B<sub>6</sub>-responsive homocystinuria and B<sub>6</sub>-non-responsive homocystinuria. B<sub>6</sub>-responsive homocystinuria is usually milder than the non-responsive variant.</p>
          <p>Thromboembolism is the major cause of early death and morbidity. IQ in individuals with untreated homocystinuria ranges widely, from 10 to 138. In B<sub>6</sub>-responsive individuals the mean IQ is 79 versus 57 for those who are B<sub>6-</sub>non-responsive. Other features that may occur include: seizures, psychiatric problems, extrapyramidal signs (e.g., dystonia), hypopigmentation of the skin and hair, malar flush, livedo reticularis, and pancreatitis.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The cardinal biochemical features of homocystinuria include markedly increased concentrations of plasma total homocysteine and methionine. The diagnosis can be substantiated by detection of biallelic pathogenic variants in <italic toggle="yes">CBS,</italic> the gene encoding cystathionine &#x003b2;-synthase.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment aims to correct the biochemical abnormalities, especially to control the plasma homocysteine concentrations and prevent thrombosis. Complications of homocystinuria should be managed appropriately; e.g., by surgery for ectopia lentis.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Individuals are treated to maintain normal or near-normal plasma total homocysteine concentrations using vitamin B<sub>6</sub> (pyridoxine) therapy (if shown to be B<sub>6</sub> responsive), a methionine-restricted diet, and folate and vitamin B<sub>12</sub> supplementation. Betaine therapy is usually added to the therapeutic regimen; in adolescents and adults, betaine may be the major form of treatment, but it is preferable to remain on life-long metabolic diet.</p>
          <p><italic toggle="yes">Surveillance:</italic> Affected individuals should be monitored at regular intervals to detect any clinical complications that may develop, for dietary compliance and for measurement of plasma total homocysteine and amino acids.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Oral contraceptives in affected females. Surgery if possible. If surgery is required, intravenous fluid with 5% dextrose in 0.5 normal saline at 1.5 times maintenance should be given and continued until oral fluids are taken ad lib, with close monitoring to avoid fluid overload.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Measurement of total homocysteine and amino acids in at-risk sibs immediately after birth ensures reduction of morbidity and mortality by early diagnosis and treatment. If the <italic toggle="yes">CBS</italic> pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of sibs</p>
          <p><italic toggle="yes">Pregnancy management:</italic> For women with classic homocystinuria: dietary treatment and betaine, and vitamin B<sub>6</sub> for those B<sub>6</sub> responsive, with careful biochemical monitoring throughout pregnancy. Prophylactic anticoagulation with low molecular-weight heparin is recommended during the third trimester and post partum to reduce risk of thromboembolism.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Homocystinuria is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the <italic toggle="yes">CBS</italic> pathogenic variants have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="homocystinuria.Diagnosis">
        <title>Diagnosis</title>
        <p>Guidelines for the diagnosis and management of classic homocystinuria have been developed in Europe [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>]. These European guidelines recommend total homocysteine (tHcy) accompanied by plasma amino acid analysis as the frontline tests for diagnosis; tHcy above 100 umol/L but occasionally lower (normal: &#x0003c;15 umol/L), when accompanied by high or borderline high methionine, makes the diagnosis very likely. For classic homocystinuria diagnosis, it is imperative that both the total plasma homocysteine concentration and the methionine concentration (as determined by plasma amino acid analysis) be obtained.</p>
        <p>Classic homocystinuria is caused by deficiency of cystathionine &#x003b2;-synthase (CBS), a pyridoxine (vitamin B<sub>6</sub>)-dependent enzyme. Because homocysteine is at the branch point between transsulfuration and methionine remethylation in the methionine metabolic cycle, a block at CBS limits transsulfuration and results in both increased homocysteine and increased methionine, the latter caused by enhanced remethylation (<xref ref-type="fig" rid="homocystinuria.F1">Figure 1</xref>).</p>
        <sec id="homocystinuria.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Homocystinuria caused by CBS deficiency (classic homocystinuria) <bold>should be suspected</bold> in newborns with an abnormal newborn screen due to increased methionine and individuals with clinical findings that range from multiple organ disease beginning in infancy or early childhood to thromboembolism only, expressed in early to middle adult years.</p>
          <sec id="homocystinuria.Newborn_Screening">
            <title>Newborn Screening</title>
            <p>Classic homocystinuria can be detected in some (not all) affected individuals by screening the newborn blood spot specimen for hypermethioninemia.</p>
            <p>The method used to measure methionine on newborn screening is tandem mass spectrometry (MS/MS). See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://genes-r-us.uthscsa.edu/sites/genes-r-us/files/nbsdisorders.pdf">National Newborn Screening Status Report</ext-link> (pdf).</p>
            <p>If the initial screening test result exceeds the cut-off level of methionine, follow-up testing is required. This may be:</p>
            <list list-type="order">
              <list-item>
                <label>1</label>
                <p>A repeat dried blood specimen submitted to the newborn screening program; or</p>
              </list-item>
              <list-item>
                <label>2</label>
                <p>Quantitative plasma amino acid analysis and analysis of plasma total homocysteine as recommended in Newborn Screening ACT Sheets and Confirmatory Algorithms for Methionine by the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.acmg.net/">American College of Medical Genetics</ext-link> (see <named-content content-type="highlight-1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/StaticContent/ACT/Methionine.pdf">ACMG ACT Sheet</ext-link></named-content> and <named-content content-type="highlight-1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/docs/ACT%20Sheets/Algorithms/Visio-Methionine.pdf">ACMG Algorithm</ext-link></named-content>).</p>
              </list-item>
            </list>
            <p>The choice between the dried blood specimen and the plasma analyses is based on the recommendation of the screening program, which usually depends on the degree of the methionine increase in the initial screen.</p>
            <p>If 1) above is selected, and if the result confirms hypermethioninemia, plasma total homocysteine analysis and plasma amino acid analysis for methionine concentration should be performed to confirm or exclude the diagnosis of classic homocystinuria (<xref ref-type="table" rid="homocystinuria.T.cardinal_biochemical_fi">Table 1</xref>).</p>
            <p>Of note:</p>
            <list list-type="bullet">
              <list-item>
                <p>At least one newborn screening program performs second-tier testing for homocysteine on all newborn specimens with elevated methionine in order to reduce the frequency of false positive results [<xref ref-type="bibr" rid="homocystinuria.REF.turgeon.2010.1686">Turgeon et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>Newborn screening is for methionine and not for homocysteine. Thus, other causes of elevated total homocysteine, such as disorders of remethylation (e.g., methylenetetrahydrofolate reductase deficiency and the cobalamin defects; see <xref ref-type="sec" rid="homocystinuria.Differential_Diagnosis">Differential Diagnosis</xref>) may not be detected because the methionine level in these disorders is reduced (or normal). Some newborn screening laboratories may flag a low methionine [<xref ref-type="bibr" rid="homocystinuria.REF.tortorelli.2010.271">Tortorelli et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>Virtually all infants with classic homocystinuria detected by newborn screening programs have had pyridoxine (vitamin B<sub>6</sub>) non-responsive homocystinuria (see <xref ref-type="sec" rid="homocystinuria.Clinical_Description">Clinical Description</xref>). It is likely very rare for infants who are pyridoxine responsive to have increased methionine during the first two to three days of life, when the newborn screening specimen is obtained.</p>
              </list-item>
              <list-item>
                <p>Measurement of total homocysteine as a primary newborn screening marker is used in Qatar, which has the highest reported incidence of homocystinuria [<xref ref-type="bibr" rid="homocystinuria.REF.ganschreier.2010.427">Gan-Schreier et al 2010</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="homocystinuria.Clinical_Findings">
            <title>Clinical Findings</title>
            <p>The major clinical findings in classic homocystinuria:</p>
            <list list-type="bullet">
              <list-item>
                <p>Ectopia lentis (dislocation of the ocular lens) and/or severe myopia</p>
              </list-item>
              <list-item>
                <p>Skeletal abnormalities (e.g., excessive height, long narrow limbs [dolichostenomelia], scoliosis, pectus excavatum) that may give the clinical impression of Marfan syndrome, but without joint hypermobility</p>
              </list-item>
              <list-item>
                <p>Vascular abnormalities characterized by thromboembolism</p>
              </list-item>
              <list-item>
                <p>Developmental delay/intellectual disability</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="homocystinuria.Establishing_the_Diagnosi">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of classic homocystinuria <bold>is established</bold> in a proband by measurement of plasma total homocysteine (tHcy) and amino acids in plasma (see <xref ref-type="sec" rid="homocystinuria.Plasma_Homocysteine_and_A">Plasma Homocysteine and Amino Acids</xref>) and/or by identification of biallelic pathogenic variants in <italic toggle="yes">CBS</italic> through molecular genetic testing (see <xref ref-type="table" rid="homocystinuria.T.molecular_genetic_testi">Table 2</xref>). Enzyme analysis of cystathionine &#x003b2;-synthase (CBS) activity may be performed if pathogenic variants are not identified.</p>
          <sec id="homocystinuria.Plasma_Homocysteine_and_A">
            <title>Plasma Homocysteine and Amino Acids</title>
            <p>Plasma homocysteine concentration must be determined in the absence of pyridoxine supplementation (including a multivitamin) for two weeks.</p>
            <p>The cardinal biochemical features, including markedly increased concentrations of plasma total homocysteine (tHcy) and methionine, are summarized in <xref ref-type="table" rid="homocystinuria.T.cardinal_biochemical_fi">Table 1</xref>.</p>
            <table-wrap id="homocystinuria.T.cardinal_biochemical_fi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Cardinal Biochemical Findings that Establish the Diagnosis of Homocystinuria</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_1">Analyte</th>
                    <th id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_2">Specimen</th>
                    <th id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Expected Findings</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3" id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Neonate with<break/>homocystinuria</th>
                    <th headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3" id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Untreated older individual<break/>with homocystinuria</th>
                    <th headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3" id="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Control</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Total homocysteine&#x000a0;<sup>1</sup> (tHcy)</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Plasma&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">50 to &#x0003e;100 &#x000b5;mol/L</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;100 &#x000b5;mol/L</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;15 &#x000b5;mol/L</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Methionine (on amino acid analysis)</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Plasma</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">200-1500 &#x000b5;mol/L<break/>(3-23 mg/dL)</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;50 &#x000b5;mol/L<break/>(&#x0003e;0.7 mg/dL)</td>
                    <td headers="hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_1_3 hd_h_homocystinuria.T.cardinal_biochemical_fi_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">10-40 &#x000b5;mol/L<break/>(0.2-0.6 mg/dL)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="homocystinuria.TF.1.1">
                  <label>1. </label>
                  <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="homocystinuria-SulfurAminoAcids.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for terms used to describe sulfur amino acids.</p>
                </fn>
                <fn id="homocystinuria.TF.1.2">
                  <label>2. </label>
                  <p>Plasma tHcy measurement is an effective method for assuring accurate diagnosis of homocystinuria. Even after a week of storage without deproteinization, virtually all tHcy can still be recovered by a method of preparation that includes a reducing agent such as dithiothreitol [<xref ref-type="bibr" rid="homocystinuria.REF.smith.1998.897">Smith et al 1998</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="homocystinuria.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel</bold>.</p>
            <p>
              <bold>Single-gene testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Sequence analysis of <italic toggle="yes">CBS</italic> is performed first and followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
              </list-item>
              <list-item>
                <p>Targeted analysis is performed only in the Qatari population, in which a single pathogenic variant (<xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Arg336Cys; c.1006C&#x0003e;T</xref>) is present in 93% of the affected population [<xref ref-type="bibr" rid="homocystinuria.REF.ganschreier.2010.427">Gan-Schreier et al 2010</xref>].</p>
              </list-item>
            </list>
            <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CBS</italic> and other genes of interest (see <xref ref-type="sec" rid="homocystinuria.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene varies by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            <table-wrap id="homocystinuria.T.molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Molecular Genetic Testing Used in Homocystinuria Caused by Cystathionine &#x003b2;-Synthase Deficiency</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">CBS</italic>
                    </td>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">95%-98%&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_2 hd_h_homocystinuria.T.molecular_genetic_testi_1_1_1_3" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="homocystinuria.TF.2.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="homocystinuria" object-id="homocystinuria.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="homocystinuria.TF.2.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="homocystinuria.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="homocystinuria.TF.2.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="homocystinuria.TF.2.4">
                  <label>4. </label>
                  <p><xref ref-type="bibr" rid="homocystinuria.REF.gaustadnes.2002.117">Gaustadnes et al [2002]</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.kruger.2003.434">Kruger et al [2003]</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.cozar.2011.835">Cozar et al [2011]</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.karaca.2014.197">Karaca et al [2014]</xref></p>
                </fn>
                <fn id="homocystinuria.TF.2.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="homocystinuria.TF.2.6">
                  <label>6. </label>
                  <p>Nine individuals with deletions or duplications involving 25 or more nucleotides have been reported to date [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ucdenver.edu/academics/colleges/medicalschool/programs/kraus/Pages/home.aspx">Kraus Lab</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cbs.lf1.cuni.cz/mutations.php"><italic toggle="yes">CBS</italic> Mutation Database</ext-link>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="homocystinuria.CBS_Enzyme_Activity_in_Cu">
            <title>CBS Enzyme Activity in Cultured Fibroblasts</title>
            <p>Analysis of CBS enzyme activity may be performed when molecular analysis fails to identify two pathogenic variants in <italic toggle="yes">CBS</italic>. CBS enzyme activity can be measured in fibroblasts [<xref ref-type="bibr" rid="homocystinuria.REF.smith.2012.186">Smith et al 2012</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.mendes.2014.245">Mendes et al 2014</xref>] or plasma [<xref ref-type="bibr" rid="homocystinuria.REF.krijt.2011.49">Krijt et al 2011</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.alcaide.2015.261">Alcaide et al 2015</xref>]. However, activity may be normal in mild cases, especially in those who are B<sub>6</sub>-responsive [<xref ref-type="bibr" rid="homocystinuria.REF.mendes.2014.245">Mendes et al 2014</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.alcaide.2015.261">Alcaide et al 2015</xref>]. Enzyme analysis cannot reliably distinguish B<sub>6</sub>-responsive from B<sub>6</sub>-non-responsive individuals.</p>
            <p>Note: Enzyme activity testing, which has been used in the past to confirm the diagnosis of homocystinuria when molecular testing genetic testing results are not diagnostic, is no longer available in the US.</p>
          </sec>
        </sec>
        <sec id="homocystinuria.Testing_Following_Establi">
          <title>Testing Following Establishment of the Diagnosis</title>
          <p><bold>Pyridoxine (B<sub>6</sub>) challenge test.</bold> The two phenotypic variants of classic homocystinuria &#x02013; B<sub>6</sub>-responsive and B<sub>6</sub>-non-responsive homocystinuria &#x02013; can have differing <xref ref-type="sec" rid="homocystinuria.Clinical_Description">natural history</xref> and <xref ref-type="sec" rid="homocystinuria.Management">management</xref>. Once the diagnosis of homocystinuria caused by deficiency of cystathionine &#x003b2; synthase (CBS) is established, a pyridoxine challenge to measure vitamin B<sub>6</sub>-responsiveness is used to determine which phenotype is present.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>In the neonate.</bold> While continuing a normal diet, plasma is obtained for baseline measurements of total homocysteine and amino acids.</p>
              <p>The affected individual is given 100 mg pyridoxine daily for two consecutive days; concentrations of plasma total homocysteine and amino acids are measured 48 hours after the first dose.</p>
              <list list-type="bullet">
                <list-item>
                  <p>A reduction of 30% or more in plasma total homocysteine and/or plasma methionine concentration suggests B<sub>6</sub> responsiveness.</p>
                </list-item>
                <list-item>
                  <p>If no significant change occurs, 200 mg pyridoxine is given orally for two consecutive days and the plasma total homocysteine and amino acid analysis are repeated after 48 hours on this dose.</p>
                </list-item>
                <list-item>
                  <p>If still no change has occurred, 300 mg of pyridoxine is given to the neonate. If plasma homocysteine and methionine concentrations are not significantly decreased after the last dose of pyridoxine, it is concluded that the individual is B<sub>6</sub>-non-responsive.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Beyond the neonatal period.</bold> For a clinically identified individual, continue a normal diet and provide folate supplement of 5 mg (for children and adults); correct B<sub>12</sub> deficiency if present. Obtain plasma for baseline measurements of total homocysteine and amino acids.</p>
              <p>The affected individual is given 100 mg pyridoxine daily for two consecutive days, and the concentrations of plasma total homocysteine and amino acids are again measured 48 hours after the first dose.</p>
              <list list-type="bullet">
                <list-item>
                  <p>A reduction of 30% or more in plasma total homocysteine and/or plasma methionine concentration suggests B<sub>6</sub> responsiveness.</p>
                </list-item>
                <list-item>
                  <p>If no significant change occurs, 200 mg pyridoxine is given orally for two consecutive days and the plasma total homocysteine and amino acid analysis are repeated after 48 hours on this dose.</p>
                </list-item>
                <list-item>
                  <p>If still no change has occurred, 500 mg of pyridoxine is given orally to a child or adult. If plasma homocysteine and methionine concentrations are not significantly decreased after the last dose of pyridoxine, it is concluded that the individual is B<sub>6</sub>-non-responsive.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: (1) Infants should not receive more than 300 mg of pyridoxine. Several infants given daily doses of 500 mg pyridoxine developed respiratory failure and required ventilatory support. The respiratory symptoms resolved on withdrawal of pyridoxine [<xref ref-type="bibr" rid="homocystinuria.REF.shoji.1998.439">Shoji et al 1998</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.mudd.2001">Mudd et al 2001</xref>]. (2) Peripheral neuropathy has been seen as an adverse effect of pyridoxine doses exceeding 900 mg per day [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>].</p>
        </sec>
      </sec>
      <sec id="homocystinuria.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="homocystinuria.Clinical_Description">
          <title>Clinical Description</title>
          <p>Homocystinuria is characterized by involvement of the eye, skeletal system, vascular system, and CNS. All four or only one of the systems can be involved. Expressivity is variable for all of the clinical signs. It is not unusual for a previously asymptomatic individual to present in adult years with only a thromboembolic event that is often cerebrovascular [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2003.259">Yap 2003</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.skovby.2010.1">Skovby et al 2010</xref>].</p>
          <p>The two phenotypic variants of classic homocystinuria are B<sub>6</sub>-responsive and B<sub>6</sub>-non-responsive homocystinuria. B<sub>6</sub>-responsive homocystinuria is typically (but not always) milder than the non-responsive variant. Vitamin B<sub>6</sub> responsiveness is determined by a pyridoxine challenge test (see <xref ref-type="sec" rid="homocystinuria.Testing_Following_Establi">Testing Following Establishment of the Diagnosis</xref>).</p>
          <p><bold>Eyes.</bold> Myopia followed by ectopia lentis typically occurs after age one year. In the majority of untreated individuals, ectopia lentis occurs by age eight years. Ectopia lentis usually occurs earlier in affected individuals who are B<sub>6</sub> non-responsive than in those who are B<sub>6</sub> responsive. Rarely, ectopia lentis occurs in infancy [<xref ref-type="bibr" rid="homocystinuria.REF.mulvihill.2001.311">Mulvihill et al 2001</xref>].</p>
          <p>High myopia may be present in the absence of ectopia lentis.</p>
          <p><bold>Skeletal system.</bold> Affected individuals are often tall and slender with a marfanoid habitus.</p>
          <p>Individuals with homocystinuria are prone to osteoporosis, especially of the vertebrae and long bones; 50% of individuals show signs of osteoporosis by their teens. Osteoporosis may be detected radiographically by lateral view of the lumbar spine or bone density studies. DXA bone density analysis usually shows reduced density in the lumbar spine and hip [<xref ref-type="bibr" rid="homocystinuria.REF.weber.2016.351">Weber et al 2016</xref>].</p>
          <p>Scoliosis, high-arched palate, arachnodactyly, pes cavus, pectus excavatum or pectus carinatum, and genu valgum are also frequently seen.</p>
          <p><bold>Vascular system.</bold> Thromboembolism is the major cause of morbidity and early death [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2003.259">Yap 2003</xref>]. It can affect any vessel. Cerebrovascular accidents have been described in infants, although problems typically appear in young adults [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2001a.2080">Yap et al 2001a</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.kelly.2003.275">Kelly et al 2003</xref>].</p>
          <p>Among B<sub>6</sub>-responsive individuals, a vascular event in adolescence or adulthood is often the presenting feature of homocystinuria [<xref ref-type="bibr" rid="homocystinuria.REF.magner.2011.33">Magner et al 2011</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.sarov.2014.257">Sarov et al 2014</xref>]. Cerebral venous sinus thrombosis has been a presenting sign in childhood [<xref ref-type="bibr" rid="homocystinuria.REF.karaca.2014.197">Karaca et al 2014</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.saboul.2015.107">Saboul et al 2015</xref>].</p>
          <p>Pregnancy increases the risk for thromboembolism, especially in the postpartum period [<xref ref-type="bibr" rid="homocystinuria.REF.novy.2010.871">Novy et al 2010</xref>]; most pregnancies, however, are uncomplicated. See <xref ref-type="sec" rid="homocystinuria.Pregnancy_Management">Pregnancy Management</xref>.</p>
          <p><bold>CNS.</bold> Developmental delay is often the first abnormal sign in individuals with homocystinuria. IQ in individuals with homocystinuria ranges from 10 to 138. B<sub>6</sub>-responsive individuals are more likely than individuals with B<sub>6</sub>-non-responsive homocystinuria to be cognitively intact or only mildly affected; the mean IQ of untreated individuals with B<sub>6</sub> responsiveness is 79 versus 57 for those who are B<sub>6</sub> non-responsive. B<sub>6</sub>-non-responsive individuals who were identified on newborn screening, received early treatment, and had good compliance (maintenance of plasma free homocystine &#x0003c;11 &#x003bc;mol/L) had a mean IQ of 105 [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2001b.437">Yap et al 2001b</xref>].</p>
          <p>Seizures occur in 21% of untreated individuals.</p>
          <p>Many individuals have psychiatric problems including personality disorder, anxiety, depression, obsessive-compulsive behavior, and psychotic episodes. Psychosis may be a presenting sign in adolescence [<xref ref-type="bibr" rid="homocystinuria.REF.hidalgo_mazzei.2014.235">Hidalgo Mazzei et al 2014</xref>].</p>
          <p>Extrapyramidal signs such as dystonia may occur.</p>
          <p><bold>Other features</bold> include hypopigmentation of the skin and hair, malar flush, livedo reticularis, and pancreatitis.</p>
        </sec>
        <sec id="homocystinuria.GenotypePhenotype_Correla">
          <title>Genotype-Phenotype Correlations</title>
          <p>The presence of a single <xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Gly307Ser</xref> allele predicts B<sub>6</sub> non-responsiveness, while presence of a <xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Ile278Thr</xref> allele usually predicts B<sub>6</sub> responsiveness [<xref ref-type="bibr" rid="homocystinuria.REF.gaustadnes.2002.117">Gaustadnes et al 2002</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.kruger.2003.434">Kruger et al 2003</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.skovby.2010.1">Skovby et al 2010</xref>]. Other pathogenic alleles are associated with either B<sub>6</sub> responsiveness or non-responsiveness [<xref ref-type="bibr" rid="homocystinuria.REF.kraus.1999.362">Kraus et al 1999</xref>].</p>
        </sec>
        <sec id="homocystinuria.Nomenclature">
          <title>Nomenclature</title>
          <p>&#x02018;Homocystinuria&#x02019; was named for excess homocystine in the urine, though now it is primarily detected by increased total homocysteine in plasma. Homocystinuria may be caused by genetically determined deficient activity of cystathionine &#x003b2;-synthase (CBS), or a variety of genetic problems that ultimately interfere with conversion of homocysteine to methionine (e.g., methylenetetrahydrofolate reductase deficiency and abnormalities of cobalamin transport or metabolism). For details on the latter conditions, see <xref ref-type="bibr" rid="homocystinuria.REF.watkins.2014">Watkins &#x00026; Rosenblatt [2014]</xref>. (See also <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">Disorders of Intracellular Cobalamin Metabolism</related-object>.)</p>
          <p>Non-genetically determined severe dietary lack of cobalamin (vitamin B<sub>12</sub> deficiency) may also cause &#x02018;homocystinuria&#x02019; [<xref ref-type="bibr" rid="homocystinuria.REF.mudd.2000.1704">Mudd et al 2000</xref>].</p>
          <p>To attain maximum specificity when using the term &#x02018;homocystinuria,&#x02019; the particular defect in question may be added; e.g., &#x02018;homocystinuria caused by CBS deficiency&#x02019; [<xref ref-type="bibr" rid="homocystinuria.REF.mudd.2000.1704">Mudd et al 2000</xref>], which has also been called &#x02018;classic homocystinuria.&#x02019;</p>
          <p>Classic homocystinuria as defined in this <italic toggle="yes">GeneReview</italic> is caused by deficiency of cystathionine &#x003b2;-synthase (CBS), a pyridoxine (vitamin B<sub>6</sub>)-dependent enzyme.</p>
        </sec>
        <sec id="homocystinuria.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence is at present undetermined; both newborn screening and clinical ascertainment underestimate prevalence because of undetected cases [<xref ref-type="bibr" rid="homocystinuria.REF.skovby.2010.1">Skovby et al 2010</xref>]. Prevalence has been reported as 1:200,000 to 1:335,000.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Qatar.</bold> The prevalence, estimated at 1:1800, may be the highest in the world [<xref ref-type="bibr" rid="homocystinuria.REF.ganschreier.2010.427">Gan-Schreier et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Ireland.</bold> Prevalence is reported to be as high as 1:65,000 [<xref ref-type="bibr" rid="homocystinuria.REF.naughten.1998.s84">Naughten et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Germany.</bold> Molecular genetic screening of a normal population estimated the prevalence of classic homocystinuria at 1:17,800 [<xref ref-type="bibr" rid="homocystinuria.REF.linnebank.2001.986">Linnebank et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Norway.</bold> Molecular genetic screening of newborns employing a panel of six pathogenic variants estimated the prevalence of classic homocystinuria at 1:6400, based on the heterozygosity rate [<xref ref-type="bibr" rid="homocystinuria.REF.refsum.2004.830">Refsum et al 2004</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="homocystinuria.Genetically_Related_Allel">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with pathogenic variants in <italic toggle="yes">CBS.</italic></p>
      </sec>
      <sec id="homocystinuria.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical condition that most closely mimics classic homocystinuria is <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>, which shares the features of long thin body habitus, arachnodactyly, and predisposition for ectopia lentis and myopia. Although ectopia lentis can also occur early in sulfite oxidase deficiency (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/272300">272300</ext-link>), this condition is clinically distinct from homocystinuria. Individuals with sulfite oxidase deficiency and Marfan syndrome have normal concentrations of plasma homocysteine and methionine.</p>
        <p>Increased concentrations of homocysteine or methionine also occur in biochemical genetic disorders that generally fall into two groups (see <xref ref-type="fig" rid="homocystinuria.F2">Figure 2</xref> and <xref ref-type="table" rid="homocystinuria.T.biochemical_aspects_of">Table 3</xref>) and can be secondary to other disorders or to nutritional aberrations:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Defects of methionine, S-adenosylmethionine, or S-adenosylhomocysteine metabolism,</bold> which typically have increased methionine concentration but normal or only slightly increased total homocysteine concentration. Included in this category are several hypermethioninemic disorders such as methionine adenosyltransferase I/III deficiency, glycine N-methyltransferase deficiency and S-adenosylhomocysteine hydrolase deficiency [<xref ref-type="bibr" rid="homocystinuria.REF.mudd.2011.3">Mudd 2011</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.bari_.2017.5">Bari&#x00107; et al 2017</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Methionine remethylation</bold> defects, which typically have increased plasma total homocysteine but low methionine concentrations. Because newborn screening is based on the detection of methionine (not homocysteine), disorders of remethylation (e.g., methylenetetrahydrofolate reductase deficiency and the cobalamin defects) may not be detected since plasma methionine concentration in these disorders is reduced (or normal). These disorders are usually folate or vitamin B<sub>12</sub> dependent [<xref ref-type="bibr" rid="homocystinuria.REF.huemer.2017.21">Huemer et al 2017</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Secondary hypermethioninemia</bold> with normal or only mildly increased total homocysteine, which can occur in liver disease associated with <related-object link-type="booklink" source-id="gene" document-id="tyrosinemia" document-type="chapter">tyrosinemia type I</related-object> [<xref ref-type="bibr" rid="homocystinuria.REF.grompe.2001.563">Grompe 2001</xref>] or <related-object link-type="booklink" source-id="gene" document-id="galactosemia" document-type="chapter">galactosemia</related-object> and in cases of excessive methionine intake from high-protein diet or methionine-enriched infant formula [<xref ref-type="bibr" rid="homocystinuria.REF.mudd.2003.15a">Mudd et al 2003</xref>]</p>
          </list-item>
        </list>
        <table-wrap id="homocystinuria.T.biochemical_aspects_of" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Biochemical Aspects of Disorders Affecting Methionine Metabolism</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Type of Defect</th>
                <th id="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disorder</th>
                <th id="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Total<break/>Homocysteine</th>
                <th id="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Methionine</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">Methionine<break/>transmethylation</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">MAT I/III deficiency&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">&#x02191;<break/>(normal, slight)</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_4" rowspan="3" valign="middle" align="left" colspan="1">&#x02191;&#x02191;</td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">GNMT deficiency&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">S-adenosylhomocysteine hydrolase deficiency</td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Transsulfuration</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Homocystinuria</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02191;&#x02191;</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x02191;&#x02191;</td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Remethylation</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">MTHFR deficiency</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">&#x02191;&#x02191;</td>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_4" rowspan="2" valign="middle" align="left" colspan="1">&#x02193;&#x02193;<break/>(rarely normal)</td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.biochemical_aspects_of_1_1_1_2" valign="middle" colspan="1" align="left" scope="col" rowspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">Cobalamin defects</related-object>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="homocystinuria.TF.3.1">
              <label>1. </label>
              <p>MAT = methionine adenosyltransferase</p>
            </fn>
            <fn id="homocystinuria.TF.3.2">
              <label>2. </label>
              <p>GNMT = glycine N-methyltransferase</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="homocystinuria.Management">
        <title>Management</title>
        <sec id="homocystinuria.Evaluations_Following_Ini">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in all individuals diagnosed with homocystinuria caused by cystathionine &#x003b2;-synthase deficiency, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a clinical geneticist/medical biochemical geneticist for additional testing and treatment plan</p>
            </list-item>
            <list-item>
              <p>Pyridoxine (vitamin B<sub>6</sub>) challenge prior to initiation of treatment (see <xref ref-type="sec" rid="homocystinuria.Testing_Following_Establi">Testing Following Establishment of the Diagnosis</xref>, <bold>Pyridoxine (B<sub>6</sub>) challenge test</bold>)</p>
            </list-item>
            <list-item>
              <p>Consultation with a genetic counselor for genetic counseling and recurrence risk counseling</p>
            </list-item>
          </list>
        </sec>
        <sec id="homocystinuria.Treatment_of_Manifestatio">
          <title>Treatment of Manifestations</title>
          <p>Treatment should be managed by a biochemical geneticist and metabolic dietician and aimed at prevention of primary manifestations of homocystinuria. For published management guidelines, see <xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al [2017]</xref>.</p>
          <p>Complications should be managed appropriately (e.g., surgery for ectopia lentis) [<xref ref-type="bibr" rid="homocystinuria.REF.neely.2001.493">Neely &#x00026; Plager 2001</xref>].</p>
        </sec>
        <sec id="homocystinuria.Prevention_of_Primary_Man">
          <title>Prevention of Primary Manifestations</title>
          <p>The principles of treatment are to correct the biochemical abnormalities &#x02012;especially to control the elevated plasma homocysteine concentrations as much as possible, to prevent or at least reduce the complications of homocystinuria [<xref ref-type="bibr" rid="homocystinuria.REF.yap.1998.738">Yap &#x00026; Naughten 1998</xref>], and to prevent further complications such as thrombosis [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>].</p>
          <p>The best results have been reported in those individuals identified by newborn screening and treated shortly after birth in whom the plasma free homocystine concentration is maintained below 11 &#x000b5;mol/L (preferably, &#x02264;5 &#x000b5;mol/L) [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2001b.437">Yap et al 2001b</xref>]. This corresponds to a plasma total homocysteine concentration below 120 &#x000b5;mol/L or, preferably, below 100 &#x000b5;mol/L [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>]. For B<sub>6</sub>-responsive individuals, the goal for plasma total homocysteine is below 50 &#x000b5;mol/L [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>].</p>
          <p>These goals may need revision when very long-term data becomes available.</p>
          <p>Measures used to control total plasma homocysteine concentration include vitamin B<sub>6</sub> (pyridoxine) therapy (if shown to be B<sub>6</sub> responsive), methionine-restricted diet, and folate and vitamin B<sub>12</sub> supplementation. Betaine therapy is usually added to the therapeutic regimen; in adolescents and adults betaine may be the major form of treatment but it is preferable to remain on life-long metabolic diet. In those who have already had a vascular event, betaine therapy alone may prevent recurrent events [<xref ref-type="bibr" rid="homocystinuria.REF.lawsonyuen.2010">Lawson-Yuen &#x00026; Levy 2010</xref>].</p>
          <p>Details about each aspect of treatment follow.</p>
          <p><bold>Vitamin B<sub>6</sub> (pyridoxine) therapy.</bold> In those who are shown to be B<sub>6</sub> responsive, treatment with pyridoxine in a dose of approximately 200 mg/day or the lowest dose that produces the maximum biochemical benefit (i.e., lowest plasma homocysteine and methionine concentrations), as determined by measurement of total homocysteine and amino acid levels, should be given.</p>
          <p>Pyridoxine may also be included in treatment despite evidence of B<sub>6</sub> non-responsiveness, typically in doses of 100-200 mg daily (although some adults receive 500-1000 mg daily).</p>
          <p><bold>Dietary treatment.</bold> B<sub>6</sub>-non-responsive neonates or those only very poorly responsive to pyridoxine require a <bold>methionine-restricted diet</bold> with frequent metabolic monitoring. This diet should be continued indefinitely. Dietary treatment should be considered for clinically diagnosed individuals but often is not tolerated if begun in mid-childhood or later.</p>
          <p>The majority of B<sub>6</sub>-responsive individuals also require a methionine-restricted diet for metabolic control.</p>
          <p>The diet for homocystinuria is very complex and the skills of an experienced metabolic dietician must be utilized. Dietary treatment reduces methionine intake by restricting natural protein intake. However, to prevent protein malnutrition, a methionine-free amino acid formula supplying the other amino acids (as well as cysteine, which may be an essential amino acid in CBS deficiency) is provided. Breast feeding may be continued in combination with the methionine-free amino acid infant formula [<xref ref-type="bibr" rid="homocystinuria.REF.macdonald.2006.299">MacDonald et al 2006</xref>]. The amount of methionine required is calculated by a metabolic dietician and supplied in natural food and special low-protein foods and monitored on the basis of plasma concentrations of total homocysteine as well as methionine.</p>
          <p><bold>Folate and vitamin B<sub>12</sub> supplementation.</bold> Folate and vitamin B<sub>12</sub> optimize the conversion of homocysteine to methionine by methionine synthase, thus helping to decrease the plasma homocysteine concentration. When the red blood cell folate concentration and serum B<sub>12</sub> concentration are reduced, folic acid is given orally at 5 mg per day; and vitamin B<sub>12</sub> is given as hydroxycobalamin at 1 mg IM per month.</p>
          <p><bold>Betaine treatment.</bold> Treatment with betaine provides an alternate remethylation pathway to convert excess homocysteine to methionine (see <xref ref-type="fig" rid="homocystinuria.F1">Figure 1</xref>) and may help to prevent complications, particularly thrombosis [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2001a.2080">Yap et al 2001a</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.lawsonyuen.2010">Lawson-Yuen &#x00026; Levy 2010</xref>]. By converting homocysteine to methionine, betaine lowers plasma total homocysteine concentrations but raises the plasma concentration of methionine.</p>
          <p>For children the initial betaine dose is 50 mg/kg twice daily, adjusted according to response (increased weekly by 50 mg/kg increments). For adults the initial dose is 3 g twice daily. The dose and frequency are adjusted according to biochemical response. There is unlikely to be any benefit in exceeding a dose of 150-200 mg/kg/day [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>].</p>
          <p>Betaine may be added to the treatment regimen in individuals poorly compliant with dietary treatment or may become the major treatment modality in those intolerant of the diet. Individuals who are pyridoxine non-responsive who were unable to attain metabolic control with diet substantially reduced their plasma homocysteine concentrations when betaine was supplemented [<xref ref-type="bibr" rid="homocystinuria.REF.singh.2004.90">Singh et al 2004</xref>].</p>
          <p>Side effects of betaine are few. (1) Some affected individuals develop a detectable body odor, resulting in reduced compliance. (2) The increase in methionine produced by betaine is usually harmless; however, cerebral edema has occurred when hypermethioninemia is extreme (&#x0003e;1000 &#x000b5;mol/L) [<xref ref-type="bibr" rid="homocystinuria.REF.yaghmai.2002.57">Yaghmai et al 2002</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.devlin.2004.545">Devlin et al 2004</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.tada.2004.1843">Tada et al 2004</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.braverman.2005.2705">Braverman et al 2005</xref>]. Eliminating betaine resulted in rapid reduction of the hypermethioninemia and resolution of the cerebral edema.</p>
          <p>Note: In a murine model for homocystinuria the effect of betaine treatment diminished significantly over time [<xref ref-type="bibr" rid="homocystinuria.REF.maclean.2012.395">Maclean et al 2012</xref>].</p>
        </sec>
        <sec id="homocystinuria.Surveillance">
          <title>Surveillance</title>
          <p>Affected individuals should be monitored at regular intervals to detect any clinical complications that may develop, to assess dietary compliance, and to measure plasma total homocysteine and methionine concentrations. Infants should be monitored monthly for the first six months of life and bimonthly until age one year, then every three months until age three years. Semiannual monitoring through the remainder of childhood and annual monitoring in adolescence and adulthood are indicated. Complications should be promptly addressed with appropriate therapy.</p>
          <p>Plasma total homocysteine and methionine concentrations should be monitored in all persons receiving betaine (see <xref ref-type="sec" rid="homocystinuria.Prevention_of_Primary_Man">Prevention of Primary Manifestations</xref>, <bold>Betaine treatment</bold>).</p>
          <p>Vitamin B<sub>12</sub> and folate levels should be monitored.</p>
          <p>Regular ophthalmology assessments can identify eye complications such as progressive myopia and ectopia lentis and allow for early treatment and prevention of further complications such as retinal detachment.</p>
          <p>DXA scans should be performed every three to five years following adolescence to monitor for osteoporosis [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>].</p>
        </sec>
        <sec id="homocystinuria.AgentsCircumstances_to_Av">
          <title>Agents/Circumstances to Avoid</title>
          <p>Oral contraceptives, which may tend to increase coagulability and represent risk for thromboembolism, should be avoided in females with homocystinuria.</p>
          <p>Surgery should also be avoided if possible because the increase in plasma homocysteine concentrations during surgery and especially post-surgery elevates the risk for a thromboembolic event. If surgery is required, intravenous fluids containing 5% dextrose in 0.5 N saline at 1.5 times maintenance should be administered before, during, and after surgery until fluids can be taken orally. If fluids at 1.5 times maintenance represent a cardiovascular risk as a result of fluid overload, basic fluid maintenance may be administered with careful clinical observation.</p>
        </sec>
        <sec id="homocystinuria.Evaluation_of_Relatives_a">
          <title>Evaluation of Relatives at Risk</title>
          <p>Plasma concentrations of total homocysteine and amino acids should be measured in at-risk sibs as soon as possible after birth so that morbidity and mortality can be reduced by early diagnosis and treatment.</p>
          <p>If the <italic toggle="yes">CBS</italic> pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of sibs.</p>
          <p>See <xref ref-type="sec" rid="homocystinuria.Related_Genetic_Counselin">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="homocystinuria.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Because women with homocystinuria may be at greater than average risk for thromboembolism, especially post partum, prophylactic anticoagulation during the third trimester of pregnancy and post partum is recommended. The usual regimen is injection of low molecular-weight heparin during the last two weeks of pregnancy and the first six weeks post partum [<xref ref-type="bibr" rid="homocystinuria.REF.pierre.2006.688">Pierre et al 2006</xref>]. Aspirin in low doses has also been given throughout pregnancy.</p>
          <p>Maternal homocystinuria, unlike maternal phenylketonuria (see <related-object link-type="booklink" source-id="gene" document-id="pku" document-type="chapter">Phenylalanine Hydroxylase Deficiency</related-object>), does not appear to have major teratogenic potential requiring additional counseling or, with respect to the fetus, more stringent management [<xref ref-type="bibr" rid="homocystinuria.REF.levy.2002.299">Levy et al 2002</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.vilaseca.2004.775">Vilaseca et al 2004</xref>]. Nevertheless, treatment with pyridoxine or methionine-restricted diet or both should be continued during pregnancy [<xref ref-type="bibr" rid="homocystinuria.REF.morris.2017">Morris et al 2017</xref>]. Betaine may also be continued and appears not to be teratogenic [<xref ref-type="bibr" rid="homocystinuria.REF.yap.2001b.437">Yap et al 2001b</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.levy.2002.299">Levy et al 2002</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.vilaseca.2004.775">Vilaseca et al 2004</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.pierre.2006.688">Pierre et al 2006</xref>].</p>
        </sec>
        <sec id="homocystinuria.Therapies_Under_Investiga">
          <title>Therapies Under Investigation</title>
          <p>CBS enzyme replacement therapy is currently in development in the preclinical phase [<xref ref-type="bibr" rid="homocystinuria.REF.bublil.2016.2372">Bublil et al 2016</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="homocystinuria.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="homocystinuria.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Homocystinuria caused by cystathionine &#x003b2;-synthase deficiency (classic homocystinuria) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="homocystinuria.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The unaffected parents of an affected individual are obligate heterozygotes (i.e., carriers of at least one <italic toggle="yes">CBS</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing homocystinuria.</p>
            </list-item>
            <list-item>
              <p>Because it is possible (though unlikely) that a parent has classic homocystinuria but has remained asymptomatic, it is appropriate to obtain a detailed medical history and perform an examination as well as plasma homocysteine and amino acid analysis in both parents. This becomes even more imperative if the mother is considering future pregnancies, as affected women are at increased risk for thromboembolic events during pregnancy.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing homocystinuria.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Because classic homocystinuria is treatable, affected individuals who have the benefit of effective treatment may be physically and intellectually normal and can reproduce.</p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with classic homocystinuria have at least one <italic toggle="yes">CBS</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The offspring of a proband whose partner is a carrier have a 50% chance of being affected and a 50% chance of being carriers.</p>
            </list-item>
            <list-item>
              <p>All offspring of a proband whose partner also has classic homocystinuria will have classic homocystinuria.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">CBS</italic> pathogenic variant.</p>
        </sec>
        <sec id="homocystinuria.Carrier_Heterozygote_Dete">
          <title>Carrier (Heterozygote) Detection</title>
          <p><bold>Molecular genetic testing.</bold> Carrier testing for at-risk family members requires prior identification of both <italic toggle="yes">CBS</italic> pathogenic variants in the family.</p>
          <p><bold>Biochemical genetic testing.</bold> A single biochemical test cannot distinguish heterozygotes for CBS deficiency from controls.</p>
          <list list-type="bullet">
            <list-item>
              <p>Heterozygotes for CBS deficiency have normal fasting plasma total homocysteine concentration.</p>
            </list-item>
            <list-item>
              <p>Plasma total homocysteine concentration response after methionine loading (100 mg methionine/kg [671 &#x000b5;mol/kg]) is abnormal in 73% of heterozygotes with pyridoxine non-responsive homocystinuria and 33% of heterozygotes with pyridoxine-responsive homocystinuria [<xref ref-type="bibr" rid="homocystinuria.REF.guttormsen.2001.204">Guttormsen et al 2001</xref>].</p>
              <p>Note: Caution should be exercised in performing a methionine loading test because adverse reactions have been reported [<xref ref-type="bibr" rid="homocystinuria.REF.cottington.2002.1046">Cottington et al 2002</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.krupkov_meixnerov_.2002.151">Krupkov&#x000e1;-Meixnerov&#x000e1; et al 2002</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="homocystinuria.Related_Genetic_Counselin">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="homocystinuria.Evaluation_of_Relatives_a">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="homocystinuria.Prenatal_Testing_and_Prei">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CBS</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>If the <italic toggle="yes">CBS</italic> pathogenic variants are unknown, measurement of CBS enzyme activity assayed in cultured amniocytes is theoretically possible. However, identifying a laboratory to perform this testing may be challenging; currently no such testing is available in the US.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="homocystinuria.Resources">
        <title>Resources</title>
      </sec>
      <sec id="homocystinuria.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">CBS</italic> has 23 exons, is 25-30 kb in length, and, depending on the tissue, is expressed as alternatively spliced mRNA isoforms with size varying from 2.5 to 3.7 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="homocystinuria" object-id="homocystinuria.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Of the 164 pathogenic variants currently identified, 67% in individuals with CBS deficiency are missense variants, the vast majority of which are private. Among the other pathogenic variants, only five are nonsense variants and the remainder are various deletions, insertions, and splicing variants (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cbs.lf1.cuni.cz/mutations.php"><italic toggle="yes">CBS</italic> Mutation Database</ext-link> for a database of current pathogenic variants) [<xref ref-type="bibr" rid="homocystinuria.REF.urreizti.2003.103">Urreizti et al 2003</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.linnebank.2004.352">Linnebank et al 2004</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.miles.2004.29871">Miles &#x00026; Kraus 2004</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.moat.2004.206">Moat et al 2004</xref>].</p>
        <p>The two most common <italic toggle="yes">CBS</italic> pathogenic variants, <xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Ile278Thr</xref> and <xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Gly307Ser</xref>, are found in exon 8.</p>
        <list list-type="bullet">
          <list-item>
            <p>p.Ile278Thr is pan ethnic; overall, it accounts for nearly 25% of all pathogenic variants, including 29% of the variant alleles in the UK and 18% in the US [<xref ref-type="bibr" rid="homocystinuria.REF.moat.2004.206">Moat et al 2004</xref>]. In some countries (e.g., Denmark) it may account for the majority of pathogenic variants [<xref ref-type="bibr" rid="homocystinuria.REF.skovby.2010.1">Skovby et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p>p.Gly307Ser is the leading cause of homocystinuria in Ireland (71% of pathogenic variants). It has also been detected frequently in US and Australian affected individuals of &#x02018;Celtic&#x02019; origin, including families of Irish, Scottish, English, French, and Portuguese ancestry. It accounts for 21% of pathogenic variants in the UK and 8% in the US [<xref ref-type="bibr" rid="homocystinuria.REF.moat.2004.206">Moat et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p><xref ref-type="table" rid="homocystinuria.T.cbs_pathogenic_variants">p.Arg336Cys</xref> is present in 93% of affected individuals in the Qatari population [<xref ref-type="bibr" rid="homocystinuria.REF.ganschreier.2010.427">Gan-Schreier et al 2010</xref>].</p>
          </list-item>
        </list>
        <table-wrap id="homocystinuria.T.cbs_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">CBS</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.833T&#x0003e;C</td>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile278Thr</td>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000071">NM_000071.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000062.1">NP_000062.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.919G&#x0003e;A</td>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly307Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1006C&#x0003e;T</td>
                <td headers="hd_h_homocystinuria.T.cbs_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg336Cys</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The primary gene splice form encodes a subunit of 63 kd. The active form of the enzyme is a homotetramer that contains one heme and one pyridoxal 5'-phosphate per each subunit [<xref ref-type="bibr" rid="homocystinuria.REF.kraus.1999.362">Kraus et al 1999</xref>, <xref ref-type="bibr" rid="homocystinuria.REF.miles.2004.29871">Miles &#x00026; Kraus 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Most pathogenic variants affect the active core of cystathionine &#x003b2;-synthase. Pathogenic variants may also impair the binding of adenosine derivatives (e.g., AMP, ATP, S-adenosylmethionine), thus interfering with cellular energy [<xref ref-type="bibr" rid="homocystinuria.REF.scott.2004.274">Scott et al 2004</xref>].</p>
      </sec>
      <sec id="homocystinuria.References">
        <title>References</title>
        <sec id="homocystinuria.Published_GuidelinesConse">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="homocystinuria.Published_GuidelinesConse.reflist0">
            <ref id="homocystinuria.REF.morris.2017">
              <mixed-citation publication-type="web">Morris AAM, Ko&#x0017e;ich V, Santra S, Andria G, Ben-Omran TIM, Chakrapani AB, Crushell E, Henderson MJ, Hochuli M, Huemer M, Janssen MCH, Maillot F, Mayne PD, McNulty J, Morrison TM, Ogier H, O&#x02019;Sullivan S, Pavl&#x000ed;kov&#x000e1; M, Talvares de Almeida I, Terry A, Yap S, Blom HJ, Chapman KA. Guidelines for the diagnosis and management of cystathionine &#x003b2;-synthase deficiency. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203861/">online</ext-link>. 2017. Accessed 5-17-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="homocystinuria.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="homocystinuria.Literature_Cited.reflist0">
            <ref id="homocystinuria.REF.alcaide.2015.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alcaide</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krijt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Sala</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Je&#x00161;ina</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Enzymatic diagnosis of homocystinuria by determination of cystathionine-&#x000df;-synthase activity in plasma using LC-MS/MS.</article-title>
                <source>Clin Chim Acta.</source>
                <year>2015</year>
                <volume>438</volume>
                <fpage>261</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25218699</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.bari_.2017.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bari&#x00107;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staufner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augoustides-Savvopoulou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobbelaere</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;nert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opladen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petkovi&#x00107; Ramad&#x0017e;a</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raki&#x00107;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wedell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>40</volume>
                <fpage>5</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">27671891</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.braverman.2005.2705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomper</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Characteristic MR imaging changes in severe hypermethioninemic states.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>26</volume>
                <fpage>2705</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16286426</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.bublil.2016.2372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bublil</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majtan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrillo</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x0016f;lkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krijt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Enzyme replacement with PEGylated cystathionine &#x003b2;-synthase ameliorates homocystinuria in murine model.</article-title>
                <source>J Clin Invest</source>
                <volume>126</volume>
                <fpage>2372</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">27183385</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.cottington.2002.1046">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cottington</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaMantia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tangerman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeisel</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Adverse event associated with methionine loading test: a case report.</article-title>
                <source>Arterioscler Thromb Vasc Biol</source>
                <volume>22</volume>
                <fpage>1046</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12067919</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.cozar.2011.835">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cozar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urreizti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dodelson de Kremer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asteggiano</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalmau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balcells</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Identification and functional analyses of CBS alleles in Spanish and Argentinian homocystinuric patients.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>835</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">21520339</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.devlin.2004.545">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Devlin</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hajipour</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gholkar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesh</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cerebral edema associated with betaine treatment in classical homocystinuria.</article-title>
                <source>J Pediatr</source>
                <volume>144</volume>
                <fpage>545</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15069409</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.ganschreier.2010.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gan-Schreier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kebbewar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang-Hoffmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdoh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahbek</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bener</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Khal</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zschocke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Newborn population screening for classic homocystinuria by determination of total homocysteine from Guthrie cards.</article-title>
                <source>J Pediatr</source>
                <volume>156</volume>
                <fpage>427</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">19914636</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.gaustadnes.2002.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaustadnes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveriusova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The molecular basis of cystathionine &#x003b2;-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment.</article-title>
                <source>Hum Mutat</source>
                <volume>20</volume>
                <fpage>117</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">12124992</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.grompe.2001.563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grompe</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The pathophysiology and treatment of hereditary tyrosinemia type 1.</article-title>
                <source>Semin Liver Dis</source>
                <volume>21</volume>
                <fpage>563</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11745044</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.guttormsen.2001.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guttormsen</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueland</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ose</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folling</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Refsum</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine &#x003b2;-synthase deficiency: relationship between genotype and phenotype.</article-title>
                <source>Am J Med Genet</source>
                <volume>100</volume>
                <fpage>204</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">11343305</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.huemer.2017.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diodato</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwahn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandeira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couce</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Cazorla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>la Marca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weisfeld-Adams</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>40</volume>
                <fpage>21</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">27905001</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.hidalgo_mazzei.2014.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hidalgo Mazzei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n Rodriguez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez Molt&#x000f3;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ru&#x000ed;z Izquierdo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baeza</surname>
                    <given-names>I.</given-names>
                  </name>
                </person-group>
                <article-title>A forgotten lethal psychosis: a case report.</article-title>
                <source>Eur Child Adolesc Psychiatry.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>235</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23812867</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.karaca.2014.197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karaca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hismi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozqul</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yilmaz</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coskun</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivri</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokatli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dursun</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>High prevalence of cerebral venous sinus thombosis (CVST) as presentation of cystathionine &#x003b2;-synthase deficiency in childhood: molecular and clinical findings of Turkish probands.</article-title>
                <source>Gene</source>
                <volume>534</volume>
                <fpage>197</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">24211323</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.kelly.2003.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furie</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kistler</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barron</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Stroke in young patients with hyperhomocysteinemia due to cystathionine &#x003b2;-synthase deficiency.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>275</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12552044</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.kraus.1999.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janosik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperandeo</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebastio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Franchis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andria</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boers</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamoun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaustadnes</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Cystathionine &#x003b2;-synthase mutations in homocystinuria.</article-title>
                <source>Hum Mutat</source>
                <volume>13</volume>
                <fpage>362</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">10338090</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.krijt.2011.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krijt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopeck&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hn&#x000ed;zda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LAJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayne</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Determination of cystathionine beta-synthase activity in human plasmas by LC-MS/MS: potential use in diagnosis of CBS deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>34</volume>
                <fpage>49</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">20821054</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.kruger.2003.434">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhee</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsas</surname>
                    <given-names>LJ</given-names>
                    <suffix>2nd</suffix>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cystathionine &#x003b2;-synthase deficiency in Georgia (USA): correlation of clinical and biochemical phenotype with genotype.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>434</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">14635102</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.krupkov_meixnerov_.2002.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krupkov&#x000e1;-Meixnerov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vesel&#x000e1;</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitov&#x000e1;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janos&#x000ed;kov&#x000e1;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Methionine-loading test: evaluation of adverse effects and safety in an epidemiological study.</article-title>
                <source>Clin Nutr</source>
                <volume>21</volume>
                <fpage>151</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12056788</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.lawsonyuen.2010">
              <mixed-citation publication-type="book">Lawson-Yuen A, Levy HL. A betaine treatment for the homocystinurias. In: Theone J, ed. <italic toggle="yes">Small Molecule Therapy for Genetic Disease</italic>. New York, NY: Cambridge University Press; 2010:173-81.</mixed-citation>
            </ref>
            <ref id="homocystinuria.REF.levy.2002.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisbren</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurczynski</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roeder</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosengren</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilfix</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacGregor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Reproductive fitness in maternal homocystinuria due to cystathionine &#x003b2;-synthase deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>25</volume>
                <fpage>299</fpage>
                <lpage>314</lpage>
                <pub-id pub-id-type="pmid">12227460</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.linnebank.2001.986">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linnebank</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homberger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Junker</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowak-Goettl</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harms</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>High prevalence of the I278T mutation of the human cystathionine &#x003b2;-synthase detected by a novel screening application.</article-title>
                <source>Thromb Haemost</source>
                <volume>85</volume>
                <fpage>986</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11434706</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.linnebank.2004.352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linnebank</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janosik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronicka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubalska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokolova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linnebank</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leyendecker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The cystathionine &#x003b2;-synthase (CBS) mutation c.1224-2A&#x0003e;C in Central Europe: Vitamin B6 nonresponsiveness and a common ancestral haplotype.</article-title>
                <source>Hum Mutat</source>
                <volume>24</volume>
                <fpage>352</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15365998</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.macdonald.2006.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depondt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendriksz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Breast feeding in IMD.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>29</volume>
                <fpage>299</fpage>
                <lpage>303</lpage>
                <pub-id pub-id-type="pmid">16763891</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.maclean.2012.395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maclean</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greiner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Long-term betaine therapy in a murine model of cystathionine &#x003b2;-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.</article-title>
                <source>Mol Genet Metab</source>
                <volume>105</volume>
                <fpage>395</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">22192524</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.magner.2011.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krupkov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honz&#x000ed;k</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hy&#x000e1;nek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Vascular presentation of cystathionine &#x003b2;-synthase deficiency in adulthood.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>34</volume>
                <fpage>33</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20567906</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.mendes.2014.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mendes</surname>
                    <given-names>MIS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cola&#x004ab;o</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DEC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>RJJF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pop</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Dooren</surname>
                    <given-names>SJM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavares De Almeida</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LAJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>MCH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomons</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leandro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Reduced response of cystathionine beta-synthase (CBS) to s-adenosylmethionine (SAM): identification and functional analysis of CBS gene mutations in homocystinuria patients.</article-title>
                <source>J inherit Metab Dis</source>
                <volume>37</volume>
                <fpage>245</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">23974653</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.miles.2004.29871">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cystathionine &#x003b2;-synthase: structure, function, regulation, and location of homocystinuria-causing mutations.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>29871</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15087459</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.moat.2004.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moat</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonham</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The molecular basis of cystathionine &#x003b2;-synthase (CBS) deficiency in UK and US patients with homocystinuria.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>206</fpage>
                <pub-id pub-id-type="pmid">14722927</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.morris.2017.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>AAM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x0017e;ich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andria</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>TIM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crushell</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochuli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>MCH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maillot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayne</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNulty</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Sullivan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavl&#x000ed;kov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talvares de Almeida</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terry</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Guidelines for the diagnosis and management of cystathionine &#x003b2;-synthase deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>40</volume>
                <fpage>49</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">27778219</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.mudd.2011.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Hypermethioninemias of genetic and non-genetic origin. A review.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <volume>157C</volume>
                <fpage>3</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21308989</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.mudd.2000.1704">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkelstein</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Refsum</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueland</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malinow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lentz</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brattstrom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selhub</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>IH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Homocysteine and its disulfide derivatives: a suggested consensus terminology.</article-title>
                <source>Arterioscler Thromb Vasc Biol</source>
                <volume>20</volume>
                <fpage>1704</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10894806</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.mudd.2003.15a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeisel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fumic</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baric</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>S-Adenosylhomocysteine (AdoHcy) hydrolase deficiency in a Croatian boy.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>26</volume>
                <supplement>Suppl 1</supplement>
                <fpage>15A</fpage>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.mudd.2001">
              <mixed-citation publication-type="book">Mudd SH, Levy HL, Kraus JP. Disorders of transulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease.</italic> 8 ed. New York, NY: McGraw Hill; 2001:2016-40</mixed-citation>
            </ref>
            <ref id="homocystinuria.REF.mulvihill.2001.311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mulvihill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Keefe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naughten</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population.</article-title>
                <source>J AAPOS</source>
                <volume>5</volume>
                <fpage>311</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11641642</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.naughten.1998.s84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Naughten</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayne</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Newborn screening for homocystinuria: Irish and world experience.</article-title>
                <source>Eur J Pediatr</source>
                <volume>157</volume>
                <supplement>Suppl 2</supplement>
                <fpage>S84</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9587032</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.neely.2001.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neely</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plager</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Management of ectopia lentis in children.</article-title>
                <source>Ophthalmol Clin North Am</source>
                <volume>14</volume>
                <fpage>493</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11705149</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.novy.2010.871">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Novy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballhausen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelillo-Scherrer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Recurrent postpartum cerebral sinus vein thrombosis as a presentation of cystathionine-&#x003b2;-synthase deficiency.</article-title>
                <source>Thromb Haemost</source>
                <volume>103</volume>
                <fpage>871</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20174770</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.pierre.2006.688">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierre</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gissen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preece</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Successful treatment of pyridoxine-unresponsive homocystinuria with betaine in pregnancy.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>29</volume>
                <fpage>688</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16972179</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.refsum.2004.830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Refsum</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fredriksen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueland</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kase</surname>
                    <given-names>BF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Birth prevalence of homocystinuria.</article-title>
                <source>J Pediatr</source>
                <volume>144</volume>
                <fpage>830</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15192637</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.saboul.2015.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saboul</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darteyre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ged</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fichtner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Inaugural cerebral sinovenous thrombosis revealing homocystinuria in a 2-year-old boy.</article-title>
                <source>J Child Neurol.</source>
                <volume>30</volume>
                <fpage>107</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">24598125</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.sarov.2014.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Not</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masnou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A case of homocystinuria due to CBS gene mutations revealed by cerebral venous thrombosis.</article-title>
                <source>J Neurol Sci</source>
                <volume>336</volume>
                <fpage>257</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24169224</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.scott.2004.274">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scullion</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norman</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardie</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.</article-title>
                <source>J Clin Invest</source>
                <volume>113</volume>
                <fpage>274</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">14722619</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.shoji.1998.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shoji</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoji</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Acute life-threatening event with rhabdomyolysis after starting on high-dose pyridoxine therapy in an infant with homocystinuria.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>21</volume>
                <fpage>439</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">9700609</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.singh.2004.90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsas</surname>
                    <given-names>LJ</given-names>
                    <suffix>2nd</suffix>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cystathionine &#x003b2;-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria.</article-title>
                <source>Genet Med</source>
                <volume>6</volume>
                <fpage>90</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15017331</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.skovby.2010.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaustadnes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A revisit to the natural history of homocystinuria due to cystathionine &#x003b2;-synthase deficiency.</article-title>
                <source>Mol Genet Metab</source>
                <volume>99</volume>
                <fpage>1</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19819175</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.smith.2012.186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendes</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smulders</surname>
                    <given-names>YM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A liquid chromatography mass spectrometry method for the measurement of cystathionine beta-synthase activity in cell extracts.</article-title>
                <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
                <volume>911</volume>
                <fpage>186</fpage>
                <lpage>191</lpage>
                <pub-id pub-id-type="pmid">23217323</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.smith.1998.897">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korson</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Inadequate laboratory technique for amino acid analysis resulting in missed diagnoses of homocystinuria.</article-title>
                <source>Clin Chem</source>
                <volume>44</volume>
                <fpage>897</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9554515</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.tada.2004.1843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohno</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Reversible white matter lesion in methionine adenosyltransferase I/III deficiency.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>25</volume>
                <fpage>1843</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15569761</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.tortorelli.2010.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tortorelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turgeon</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day-Salvatore</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdenur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorey</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichter-Konecki</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oglesbee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrilov</surname>
                    <given-names>DK</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry.</article-title>
                <source>J Pediatr</source>
                <volume>157</volume>
                <fpage>271</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20394947</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.turgeon.2010.1686">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turgeon</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magera</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuthbert</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loken</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavilov</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortorelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oglesbee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry.</article-title>
                <source>Clin Chem</source>
                <volume>56</volume>
                <fpage>1686</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">20807894</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.urreizti.2003.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urreizti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balcells</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldellou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couce</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinberg</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Spectrum of CBS mutations in 16 homocystinuric patients from the Iberian Peninsula: high prevalence of T191M and absence of I278T or G307S.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>103</fpage>
                <pub-id pub-id-type="pmid">12815602</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.vilaseca.2004.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuartero</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez de Salinas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambruschini</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urreizti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balcells</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinberg</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Two successful pregnancies in pyridoxine-nonresponsive homocystinuria.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>27</volume>
                <fpage>775</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15617186</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.watkins.2014">
              <mixed-citation publication-type="web">Watkins D, Rosenblatt DS. Inherited disorders of folate and cobalamin transport and metabolism. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 155. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. 2014. Accessed 5-15-17.</mixed-citation>
            </ref>
            <ref id="homocystinuria.REF.weber.2016.351">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coughlin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindstrom</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ficicioglu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freehauf</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Low bone mineral density is a common finding in patients with homocystinuria.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2016</year>
                <volume>117</volume>
                <fpage>351</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">26689745</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.yaghmai.2002.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yaghmai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashani</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okoh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomper</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tangerman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudd</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine &#x003b2;-synthase (CBS) deficiency.</article-title>
                <source>Am J Med Genet</source>
                <volume>108</volume>
                <fpage>57</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11857551</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.yap.2003.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Classical homocystinuria: vascular risk and its prevention.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>26</volume>
                <fpage>259</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">12889665</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.yap.2001a.2080">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boers</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenton</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naughten</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Vascular outcome in patients with homocystinuria due to cystathionine &#x003b2;-synthase deficiency treated chronically: a multicenter observational study.</article-title>
                <source>Arterioscler Thromb Vasc Biol</source>
                <volume>21</volume>
                <fpage>2080</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11742888</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.yap.1998.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naughten</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Homocystinuria due to cystathionine &#x003b2;-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>21</volume>
                <fpage>738</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">9819703</pub-id>
              </element-citation>
            </ref>
            <ref id="homocystinuria.REF.yap.2001b.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rushe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naughten</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine &#x003b2;-synthase deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>24</volume>
                <fpage>437</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">11596648</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="homocystinuria.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="homocystinuria.Suggested_Reading.reflist0">
            <ref id="homocystinuria.REF.sahai.2009.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sahai</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Newborn screening.</article-title>
                <source>Crit Rev Clin Lab Sci.</source>
                <volume>46</volume>
                <fpage>55</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">19255915</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="homocystinuria.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="homocystinuria.Author_Notes">
          <title>Author Notes</title>
          <p>Authors&#x02019; website: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://newenglandconsortium.org">New England Consortium of Metabolic Programs</ext-link></p>
        </sec>
        <sec id="homocystinuria.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>18 May 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 November 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 April 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 March 2006 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 August 2005 (cd) Revision: sequence analysis of entire coding region no longer clinically available</p>
            </list-item>
            <list-item>
              <p>15 January 2004 (ca) Review posted live</p>
            </list-item>
            <list-item>
              <p>2 September 2003 (hl) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="homocystinuria.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Methionine metabolic pathway</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="homocystinuria-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="homocystinuria.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Pathway demonstrating disorders in the biochemical differential diagnosis for homocystinuria</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="homocystinuria-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
